These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8585104)

  • 1. Kinetics and dynamics of sematilide.
    Shi J; Lasser T; Koziol T; Hinderling PH
    Ther Drug Monit; 1995 Oct; 17(5):437-44. PubMed ID: 8585104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sematilide in renal failure.
    Shi J; Ripley E; Gehr TW; Sica DA; Dandekar KA; Hinderling PH
    J Clin Pharmacol; 1996 Feb; 36(2):131-43. PubMed ID: 8852389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
    Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
    Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS; Gottlieb SS; Singh BN; Ramanathan KB; Ogilby JD; Ellenbogen KA
    J Am Coll Cardiol; 1995 Dec; 26(7):1679-84. PubMed ID: 7594103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.
    Wong W; Pavlou HN; Birgersdotter UM; Hilleman DE; Mohiuddin SM; Roden DM
    Am J Cardiol; 1992 Jan; 69(3):206-12. PubMed ID: 1731461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of sematilide in plasma by high-performance liquid chromatography.
    Dancik S; Koziol T; Nisperos E; Woolf E
    J Pharm Sci; 1991 Feb; 80(2):157-9. PubMed ID: 2051320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative kinetics of sematilide in four species.
    Hinderling PH; Dilea C; Koziol T; Millington G
    Drug Metab Dispos; 1993; 21(4):662-9. PubMed ID: 8104126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics and dynamics of nicainoprol, a new antiarrhythmic agent, in humans.
    Ishizaki T; Horai Y; Kubota K; Minegishi A; Echizen H; Chiba K
    Clin Pharmacol Ther; 1987 Nov; 42(5):525-34. PubMed ID: 3677541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate-dependent effects of sematilide on ventricular monophasic action potential duration and delayed rectifier K+ current in rabbits.
    Beatch GN; Davis DR; Laganière S; Williams BA
    J Cardiovasc Pharmacol; 1996 Nov; 28(5):618-30. PubMed ID: 8945674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models.
    Xue YX; Eto K; Akie Y; Hashimoto K
    Jpn J Pharmacol; 1996 Feb; 70(2):129-38. PubMed ID: 8866750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of direct negative chronotropic and positive inotropic effects of sematilide to those of E-4031 and MS-551 and the reverse frequency-dependent prolongation of cardiac refractoriness of sematilide.
    Yamada A; Motomura S; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):159-66. PubMed ID: 8656651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.
    Chen J; Komori S; Li B; Tamura K; Hashimoto K
    Br J Pharmacol; 1996 Nov; 119(5):937-42. PubMed ID: 8922743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic assay for sematilide in plasma using solid-phase extraction microcolumn technology.
    Laganière S; Goernert L; Beatch G
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):191-5. PubMed ID: 7858714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of the class III antiarrhythmic agent dofetilide (UK-68,798) in humans.
    Tham TC; MacLennan BA; Burke MT; Harron DW
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):507-12. PubMed ID: 7681516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues.
    Argentieri TM; Carroll MS; Sullivan ME
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):167-74. PubMed ID: 1719286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sematilide, a novel class III antiarrhythmic agent, on delayed rectifier K+ current in guinea pig atrial myocytes.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Jpn J Pharmacol; 1996 Aug; 71(4):361-5. PubMed ID: 8886937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.
    Sedgwick M; Rasmussen HS; Walker D; Cobbe SM
    Br J Clin Pharmacol; 1991 May; 31(5):515-9. PubMed ID: 1888617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.